Dr. Marina Kushnirsky, MD

Dr. Kushnirsky practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Dr. Kushnirsky's NPI, 1124559166, was assigned on March 22, 2017. Dr. Kushnirsky graduated from Zucker School of Medicine in 2017. Dr. Kushnirsky holds Florida license ME163358.

Dr. Kushnirsky's primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Dr. Kushnirsky's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. Dr. Kushnirsky is also affiliated with Jackson Memorial Hospital. The medical group on file is University of Miami Health System.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kushnirsky practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Kushnirsky's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Kushnirsky is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Kushnirsky's licenses on file in 2 states: Florida and New York.

CMS data shows 133 Medicare services from Dr. Kushnirsky across 3 procedure codes in 2024, for 62 Medicare patients. Medicare paid $16,439 for them.

CMS counts 62 Medicare patients who saw Dr. Kushnirsky in 2024. The largest group is 65 to 74, with 29 patients. 71% of them have high blood pressure, and 69% have high cholesterol. 27% are also on Medicaid. Their average risk score is 2.08, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kushnirsky's median patient age at 68, with 62% women.

In 2024, Dr. Kushnirsky wrote 289 Medicare Part D claims for 49 patients. 90% of them were for generic drugs. CMS names the drug for 217 of them, across 8 drugs with 11 or more claims each, at $18,642 in total drug cost. In 2023, CMS named 139 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Kushnirsky for performance year 2024, reported as part of a group. Dr. Kushnirsky accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kushnirsky as offering telehealth.

Dmand AI links 8 papers to Dr. Kushnirsky, published from 2015 to 2022. 2020 was the busiest year, with 5. The most frequent topics are Brain Neoplasms, Brain Ischemia and Stroke. Dr. Kushnirsky's most frequent co-authors are Sebastian Koch, MD, Dileep Rajhavendra Yavagal, MD and Macarena Ines De La Fuente, MD.

CMS Open Payments shows 9 general payments to Dr. Kushnirsky from 4 drug and device companies from 2017 to 2025. Travel and lodging make up the largest share, 73% of the total. Telix Pharmaceuticals paid the most, $1,442.

Dr. Kushnirsky graduated from Zucker School of Medicine in 2017.

Dr. Kushnirsky is in network with 11 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 6. Check the plan with the practice before a visit.